home / stock / harp / harp news

HARP News and Press, Harpoon Therapeutics Inc. From 11/05/20

Stock Information
Company Name: Harpoon Therapeutics Inc.
Stock Symbol: HARP
Market: NASDAQ
Website: harpoontx.com
Menu
HARP HARP Quote HARP Short HARP News HARP Articles HARP Message Board
Get HARP Alerts

News, Short Squeeze, Breakout and More Instantly...
HARP - Harpoon Therapeutics Abstract for HPN601 EpCAM ProTriTAC(TM) Program Accepted for Oral Presentation at Upcoming 35th SITC Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, announced today that the preclinical data on HPN601 for the treatment of solid tumors has been accepted for oral...
HARP - Harpoon Therapeutics EPS in-line, misses on revenue

Harpoon Therapeutics (HARP): Q3 GAAP EPS of -$0.53 in-line.Revenue of $3.89M (+173.9% Y/Y) misses by $0.77M.Press Release For further details see: Harpoon Therapeutics EPS in-line, misses on revenue

HARP - Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today reported financial results for the third quarter ended September 30, 2020 and provided a corpor...

HARP - Harpoon Therapeutics Appoints Omer Siddiqui as VP Development Operations and Project Management

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced the appointment of Omer Siddiqui as Vice President, Development Operations and Projec...
HARP - Harpoon Therapeutics to Participate in the Cantor Virtual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate ...

HARP - DOCU, CRWD among premarket gainers

Guess' (NYSE: GES ) +25%  on Q2 results . More news on: Guess', Inc., TSR, Inc., Vera Bradley, Inc., Stocks on the move, , Read more ...

HARP - AMRN, DVAX among premarket gainers

Aimmune Therapeutics (NASDAQ: AIMT ) +171%  on being acquired by Nestle. More news on: Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., Genworth Financial, Inc., , , Read more ...

HARP - Harpoon Therapeutics Names Karin Ann Thacker, M.Sc., VP Regulatory Affairs and Quality Assurance

SOUTH SAN FRANCISCO, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced the appointment of Karin Ann Thacker, M.Sc., as Vice President, Regulatory Affairs an...

HARP - RIG, RKT among premarket gainers

Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +67%  on FDA nod for convalescent plasma. More news on: Sonnet BioTherapeutics Holdings, Inc., Liminal BioSciences Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...

HARP - GEVO, GME, TOPS and BKE among midday movers

Gainers:  Hancock Jaffe Laboratories (NASDAQ: HJLI ) +127% . More news on: Hancock Jaffe Laboratories, Inc., Harpoon Therapeutics, Inc., ShiftPixy, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10